References
- 1. Y. Kwon, Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy, OncoTargets Ther.9 (2016) 2007–2016; https://doi.org/10.2147/OTT.S96899
- 2. B. Lončar Brzak and M. Mravak Stipetić, Scales for the assessment of oral mucositis, Medix20 (2014) 213–216.
- 3. M. Muhvić Urek, I. Glažar, A. Braut, and S. Pezelj-Ribarić, Radiation induced oral mucositis – therapeutic strategy in a case report, Med. Flum.51 (2015) 310–317.
- 4. D. I. Rosenthal and A. Trotti, Strategies for managing radiation-induced mucositis in head and neck cancer, Semin. Radiat. Oncol.19 (2009) 29–34; https://doi.org/10.1016/j.semradonc.2008.09.006
- 5. P. Franco, S. Martini, J. Di Muzio, C. Cavallin, F. Arcadipane, M. Rampino, O. Ostellino, G. Pecorari, P. G. Demo, M. Fasolis and M. Airoldi, Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer, Med. Oncol.34 (2017) 81; https://doi.org/10.1007/s12032-017-0950-1
- 6. R. V. Lalla, S. T. Sonis and D. E. Peterson, Management of oral mucositis in patients who have cancer, Dent. Clin. North Am. 52 (2008) 61–77; https://doi.org/10.1016/j.cden.2007.10.002
- 7. D. B. McGuire, M. E. P. Correa, J. Johnson and P. Wienandts, The role of basic oral care and good clinical practice principles in the management of oral mucositis, Support. Care Cancer14 (2006) 541–547; https://doi.org/10.1007/s00520-006-0051-8
- 8. J. A. Kushner, H. P. Lawrence, I. Shoval, T. L. Kiss, G. M. Devins, L. Lee and H. C. Tenenbaum, Development and validation of a Patient-Reported Oral Mucositis Symptom (PROMS) scale, J. Can. Dent. Assoc.74 (2008) 59a-59j; http://www.cda-adc.ca/jcda/vol-74/issue-1/59.pdf
- 9. A. Shankar, S. Roy, M. Bhandari, G. K. Rath, A. S. Biswas, R. Kanodia, N. Adhikari and R. Sachan, Current trends in management of oral mucositis in cancer treatment, Asian Pac. J. Cancer Prev.18 (2017) 2019–2026; https://doi.org/10.22034/APJCP.2017.18.8.2019
- 10. Y. Shao and H. Zhou, Clinical evaluation of a toothpaste containing lysozyme for the treatment of recurrent aphthous stomatitis: A 3-month, double-blind, randomized study, Am. J. Dent. 29 (2016) 303–306.
- 11. S. A. Ragland and A. K. Criss, From bacterial killing to immune modulation: Recent insights into the functions of lysozyme, PLoS Pathog.13 (2017) e1006512; https://doi.org/10.1371/journal.ppat.1006512
- 12. T. G. Villa and P. V. Crespo, Enzybiotics: Antibiotic enzymes as drugs and therapeutics, Wiley. Com. 2010. (Online); https://www.wiley.com/en-rs/Enzybiotics%3A+Antibiotic+Enzymes+as+Drugs+and+Therapeutics-p-9780470570531 (last access November 20, 2018).
- 13. F. T. Károly, P. Hermann, A. Beck, P. Fejérdy and G. Fábián, Salivary defense proteins: their network and role in innate and acquired oral immunity, Int. J. Mol. Sci.13 (2012) 4295–4320; https://doi.org/10.3390/ijms13044295
- 14. T. Catic, M. Mehic, A. Lokvancic and B. Kapo, Lysozyme – enzybiotic as a potential solution of the global problem of antibiotic resistance, Farm. Glas.73 (2017) 273–288.
- 15. I. Dozić and T. Todorović, Antimicrobial proteins of human saliva, Serbian Dent. J.52 (2005) 208–216; https://scindeks-clanci.ceon.rs/data/pdf/0039-1743/2005/0039-17430504208D.pdf
- 16. E. Gajda and G. Bugla-Płoskońska, Lysozyme-occurrence in nature, biological properties and possible applications, Postepy Hig. Med. Doswiadczalnej Online68 (2014) 1501–1515; https://doi.org/10.5604/17322693.1133100
- 17. M. Derde, V. Vié, A. Walrant, S. Sagan, V. Lechevalier, C. Guérin-Dubiard, S. Pezennec, M. F. Cochet, G. Paboeuf, M. Pasco and F. Baron, Antimicrobial activity of lysozyme isoforms: Key molecular features, Biopolymers107 (2017); https://doi.org/10.1002/bip.23040
- 18. Y. H. Samaranayake, B. P. Cheung, N. Parahitiyawa, C. J. Seneviratne, J. Y. Yau, K. W. Yeung and L. P. Samaranayake, Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces, Arch. Oral Biol.54 (2009) 115–126; https://doi.org/10.1016/j.archoralbio.2008.09.015
- 19. E. Karolewska, T. Konopka, M. Pupek, A. Chybicka and M. Mendak, Antibacterial potential of saliva in children with leukemia, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.105 (2008) 739–744; https://doi.org/10.1016/j.tripleo.2007.10.010
- 20. T. Sobue, M. Bertolini, A. Thompson, D. E. Peterson, P. I. Diaz and A. Dongari-Bagtzoglou, Chemotherapy-induced oral mucositis and associated infections in a novel organotypic model, Mol. Oral Microbiol.33 (2018) 212–223; https://doi.org/10.1111/omi.12214
- 21. S. Raj, D. Sharma, P. Mate, M. R. Capoor and K. T. Bhowmik. A study of changes in the oral fungal flora of patients on radiotherapy for head and neck malignancies and their correlation with funguria and fungemia, Indian. J. Cancer. 54 (2017) 39–42; https://doi.org/10.4103/ijc.IJC_155_17
- 22. H. R. Ibrahim, K. Hamasaki and T. Miyata, Novel peptide motifs from lysozyme suppress pro-inflammatory cytokines in macrophages by antagonizing toll-like receptor and LPS-scavenging action, Eur. J. Pharm. Sci.107 (2017) 240–248; https://doi.org/10.1016/j.ejps.2017.07.005